Company Directory > Biotech > Dankook University

Dankook University

Yongin and Cheonan, South Korea
VISIT WEBSITE
Dankook University is a prominent private research university in South Korea, recognized as a major hub for pharmaceutical, medical, and dental innovation. The university operates two main campuses in Jukjeon and Cheonan, with the latter serving as a specialized cluster for bio-health and medical sciences. It is home to the Dankook University Hospital (DKUH), a leading regional clinical trial center, and several world-class research institutes including the Institute of Tissue Regeneration Engineering (ITREN) and the Beckman Laser Institute Korea. The university is a significant contributor to the global biotechnology sector through its technology transfer office and high-profile spin-offs. Its most notable commercial success is Rznomics Inc., a clinical-stage biotech founded by DKU Professor Seong-wook Lee, which specializes in proprietary RNA editing technology. Dankook University maintains a strong focus on regenerative medicine, oncology, and medical device development, frequently partnering with global pharmaceutical leaders like Eli Lilly and Charles River Laboratories to advance its research into commercial therapies.
CLASSIFICATION
Company Type:Biotech
Industry:Biotechnology
Sub-Industry:Academic Research & Drug Discovery
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$100M-$500M (Institutional Budget)
Founded:1947
Ownership:nonprofit
Status:operating
FUNDING
Investors:South Korean Government (Ministry of Science and ICT), Ministry of Health and Welfare
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 1b/2a (RZ-001)
Modalities:RNA Editing, Gene Therapy, Biomaterials, Small Molecule, Medical Lasers
Active Trials:45
Trial Phases:Phase 1: 12 | Phase 2: 18 | Phase 3: 10 | Phase 4: 5
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Dankook University Hospital, Dankook University Dental Hospital, Rznomics Inc. (Spin-off), ITREN (Institute of Tissue Regeneration Engineering)
Key Partnerships:Eli Lilly (Co-development of RNA editing for hearing loss), Charles River Laboratories (Viral vector CDMO partnership), Harvard University Hospital (Expanded Access Program for RZ-001), Novotech (Clinical trial capability enhancement), Glory Biotechnologies (Biomarker and diagnostic equipment development)
COMPETITION
Position:Leader
Competitors:Seoul National University, Yonsei University, KAIST, Sungkyunkwan University
LEADERSHIP
Key Executives:
Ahn Soon-cheol - President
Kim Kyu-bong - Dean, College of Pharmacy
Seong-wook Lee - Professor & CEO of Rznomics
Scientific Founders:Seong-wook Lee (Founder of Rznomics)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Dankook University. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.